Lanean...
Perspectives on the clinical development of immunotherapy in prostate cancer
Despite impressive survival benefits with immunotherapy in patients with various solid tumors, the full potential of these agents in prostate cancer has yet to be realized. Sipuleucel-T demonstrated a survival benefit in this population, indicating that prostate cancer is an immunoresponsive disease...
Gorde:
| Argitaratua izan da: | Asian J Androl |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Medknow Publications & Media Pvt Ltd
2018
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5952479/ https://ncbi.nlm.nih.gov/pubmed/29582792 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/aja.aja_9_18 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|